Anticoagulation therapy
Prior CABG.
Active bleeding or at high risk of bleeding
Severe liver or renal disease.
Hypersensitivity to ticagrelor
History of intracranial hemorrhage

NCT02627521_exc_T1
Procedure
Anticoagulation therapy
NCT02627521_exc_T2
Temporal
Prior
NCT02627521_exc_T3
Procedure
CABG
NCT02627521_exc_T4
Qualifier
Active
NCT02627521_exc_T5
Condition
bleeding
NCT02627521_exc_T6
Qualifier
at high risk
NCT02627521_exc_T7
Condition
bleeding
NCT02627521_exc_T8
Condition
renal disease
NCT02627521_exc_T9
Condition
ease.
H er or
NCT02627521_exc_T10
Qualifier
Severe
NCT02627521_exc_T11
Scope
liver or renal disease
NCT02627521_exc_T12
Condition
Hypersensitivity
NCT02627521_exc_T13
Drug
ticagrelor
NCT02627521_exc_T14
Observation
History
NCT02627521_exc_T15
Condition
intracranial hemorrhage